HEM:CC Message Board Post 6471606 | Hemostemix Inc.
home / stock / hem:cc / hem:cc message board
daniisable80
Member
Posted on: Apr/13/2023 08:40:42
Source: mwn
Hemostemix Inc. ($HEM) is also developing a cell therapy for the treatment of critical limb ischemia (CLI) and chronic ischemic heart disease (CHD). The company's other products include a stem cell-based product for the treatment of erectile dysfunction and a stem cell-based product for the treatment of acute myocardial infarction. There are 81,089,626 outstanding listed shares.
News, Short Squeeze, Breakout and More Instantly...
-
Calgary, Alberta--(Newsfile Corp. - June 11, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it was notified by the World Intellectual Property Organization that it was granted the trademark Your Fountain of Youth by the Swiss Trademark Office. "In four h...
-
2024-06-03 13:23:23 ET In a press release this morning, %Hemostemix Inc. (TSXV: $HEM) (OTC: $HMTXF) announced it had signed a Letter of Intent ("LOI") with CytoImmune Therapeutics. The LOI will re-establish production of ACP-01 ("ACP") in CytoImmune's state-of-the-art clinical cell manu...
-
Calgary, Alberta--(Newsfile Corp. - June 3, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) is pleased to announce it has signed a Letter of Intent ("LOI") with CytoImmune Therapuetics ("CytoImmune") to re-establish production of ACP-01 ("ACP") in CytoImmune's state-of-the-art c...